BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)

3.21
Delayed Data
As of 3:49pm ET
 +0.05 / +1.58%
Today’s Change
2.35
Today|||52-Week Range
62.00
-65.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization161.6K162.3K123.6K72.3K
 
 
 
 
 
 
Operating ExpensesGross Income-161.6K-162.3K-123.6K-72.3K
 
 
 
 
 
General Expenses2.7M2.9M6.5M21.4M
 
 
 
 
 
Research And Development1.9M1.9M5.2M19.9M
 
 
 
 
 
Total Operating Expenses2.9M3.1M6.6M21.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.9M-3.1M-6.6M-21.4M
 
 
 
 
 
Extraordinary Credit145.1K774.7K--558.8K
 
 
 
 
Extraordinary Charge0.000.00-2.2M--
 
 
Interest Expense On Debt6.2K7.1K20.5K3.8M
 
 
 
 
 
Other Expenses142.3K-72.1K-804.4K230.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.6M-2.4M-9.7M-24.4M
 
 
 
 
 
Net Income-2.6M-2.4M-9.7M-24.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6M3.4M5.0M6.5M
 
 
 
 
 
Shares To Calculate EPS Diluted2.6M3.4M5.0M6.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.03-$0.73-$1.91-$3.73
 
 
 
 
 
EPS Diluted-$1.03-$0.73-$1.91-$3.73